A Khavinson-school immunogeroprotective peptide mapped mainly through cytokine and ageing-immune Russian titles.
synthetic immunopeptide
synthetic immunopeptide (sequence not fixed on this page)
School writing places crystagen in the immunogeroprotective peptide family. No single archive sequence label is asserted here.
Crystagen sits in the Khavinson immunogeroprotective peptide family beside vilon, epithalon and related labels in cytokine comparison papers.
This archive does not assert a fixed residue string for crystagen on the identity plate. Sequence claims elsewhere on the web are left unverified here.
We keep it because the IL-18 signature and Far North worker cohort papers give a usable immune trail.
Themed chapters drawn only from papers already mapped on this dossier. Archive map. No medical advice.
Maksimenia, Fefelova and Bykova (2016) compare natural and synthetic peptides on cytokine production by peripheral-blood cells. Synthesis notes crystagen increases IL-18, with distinct signatures for vilon, endoluten and related peptides in the same assay.
Adjacent Russian titles discuss immunomodulating peptides reducing spleen-cell apoptosis during ageing, and peptidergic regulation of macrophage subpopulations in the ageing immune system.
A Far North morbidity-prevention title (Trofimova 2016) and proliferotrope organ titles sit in the applied neighbourhood. Food-biotechnology and bioantioxidant chips from the prior map are dropped as off-focus.
The usable trail is cytokine comparison plus ageing-immune Russian titles. No PubMed rows were attached in the prior map.
Gymnast adaptation and general medicinal-peptide reviews are kept only where peptide bioregulation is explicit.
7 in corpus · off-focus food biotechnology and bioantioxidant chips removed
No PubMed-indexed rows mapped for this entry in the current corpus.
Reviewed against the archive corpora on 2026-09-19. Source-grounded. No clinical claims. Archive / history / research only. No medical advice. No dosing, synthesis, sourcing, or health claims.